Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney

Abstract Introduction: While recent investigations show that klotho exerts renoprotective actions, it has not been fully addressed whether klotho protein supplementation reverses renal damage. Methods: The impacts of subcutaneous klotho supplementation on rats with subtotal nephrectomy were examined...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney & blood pressure research 2023-01, Vol.48 (1), p.326-337
Hauptverfasser: Takenaka, Tsuneo, Hasan, Arif, Marumo, Takeshi, Inoue, Tsutomu, Miyazaki, Takashi, Suzuki, Hiromichi, Kurosaki, Yoshifumi, Ishii, Naohito, Nishiyama, Akira, Hayashi, Matsuhiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 337
container_issue 1
container_start_page 326
container_title Kidney & blood pressure research
container_volume 48
creator Takenaka, Tsuneo
Hasan, Arif
Marumo, Takeshi
Inoue, Tsutomu
Miyazaki, Takashi
Suzuki, Hiromichi
Kurosaki, Yoshifumi
Ishii, Naohito
Nishiyama, Akira
Hayashi, Matsuhiko
description Abstract Introduction: While recent investigations show that klotho exerts renoprotective actions, it has not been fully addressed whether klotho protein supplementation reverses renal damage. Methods: The impacts of subcutaneous klotho supplementation on rats with subtotal nephrectomy were examined. Animals were divided into 3 groups: group 1 (short remnant [SR]): remnant kidney for 4 weeks, group 2 (long remnant [LR]): remnant kidney for 12 weeks, and group 3 (klotho supplementation [KL]): klotho protein (20 μg/kg/day) supplementation on the remnant kidney. Blood pressure, blood and urine compositions with conventional methods such as enzyme-linked immunosorbent assay and radioimmunoassay, kidney histology, and renal expressions of various genes were analyzed. In vitro studies were also performed to support in vivo findings. Results: Klotho protein supplementation decreased albuminuria (−43%), systolic blood pressure (−16%), fibroblast growth factor (FGF) 23 (−51%) and serum phosphate levels (−19%), renal angiotensin II concentration (−43%), fibrosis index (−70%), renal expressions of collagen I (−55%), and transforming growth factor β (−59%) (p < 0.05 for all). Klotho supplementation enhanced fractional excretion of phosphate (+45%), glomerular filtration rate (+76%), renal expressions of klotho (+148%), superoxide dismutase (+124%), and bone morphogenetic protein (BMP) 7 (+174%) (p < 0.05 for all). Conclusion: Our data indicated that klotho protein supplementation inactivated renal renin-angiotensin system, reducing blood pressure and albuminuria in remnant kidney. Furthermore, exogenous klotho protein supplementation elevated endogenous klotho expression to increase phosphate excretion with resultant reductions in FGF23 and serum phosphate. Finally, klotho supplementation reversed renal dysfunction and fibrosis in association with improved BMP7 in remnant kidney.
doi_str_mv 10.1159/000530469
format Article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_proquest_journals_2906763385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_bb794bd802e6476990d5baa2e0a9c81e</doaj_id><sourcerecordid>2797146828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-47e797d0c369c8c15ae03a9fb367ada8a0cf2125266721c220e7f71960463b3b3</originalsourceid><addsrcrecordid>eNptkc-L1TAQx4so7rp68C5S8KKH6iRpk-a4rq4-3oKw6lFCmk7XPNukJqnw_nvzfvgEkRwyzHzy_U5miuIpgdeENPINADQMai7vFeekpqwCUrP7-xiqGiQ_Kx7FuNlhAPRhccYEEAlSnBff1qNP3335eZnnESd0SSfrXXmLvzBEjDlweizfbeOwOLMvadeXK5dyOdlkc_HadsFHG0u7ezc57VK5tr3D7ePiwaDHiE-O90Xx9fr9l6uP1c2nD6ury5vKNFSmqhYopOjBMC5Na0ijEZiWQ8e40L1uNZiBEtpQzgUlhlJAMQgief4z6_K5KFYH3d7rjZqDnXTYKq-t2id8uFM6JGtGVF0nZN31LVDkteBSQt90WlMEnb0JZq2XB605-J8LxqQmGw2Oo3bol6hobpXUvKVtRl_8g278EvK8MiWBC85Y22Tq1YEyeUox4HBqkIDa7U-d9pfZ50fFpZuwP5F_FvbX8ocOdxhOwPrt7UFCzf2QqWf_pY4uvwFLNKjD</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2906763385</pqid></control><display><type>article</type><title>Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney</title><source>DOAJ Directory of Open Access Journals</source><source>Karger Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Takenaka, Tsuneo ; Hasan, Arif ; Marumo, Takeshi ; Inoue, Tsutomu ; Miyazaki, Takashi ; Suzuki, Hiromichi ; Kurosaki, Yoshifumi ; Ishii, Naohito ; Nishiyama, Akira ; Hayashi, Matsuhiko</creator><creatorcontrib>Takenaka, Tsuneo ; Hasan, Arif ; Marumo, Takeshi ; Inoue, Tsutomu ; Miyazaki, Takashi ; Suzuki, Hiromichi ; Kurosaki, Yoshifumi ; Ishii, Naohito ; Nishiyama, Akira ; Hayashi, Matsuhiko</creatorcontrib><description>Abstract Introduction: While recent investigations show that klotho exerts renoprotective actions, it has not been fully addressed whether klotho protein supplementation reverses renal damage. Methods: The impacts of subcutaneous klotho supplementation on rats with subtotal nephrectomy were examined. Animals were divided into 3 groups: group 1 (short remnant [SR]): remnant kidney for 4 weeks, group 2 (long remnant [LR]): remnant kidney for 12 weeks, and group 3 (klotho supplementation [KL]): klotho protein (20 μg/kg/day) supplementation on the remnant kidney. Blood pressure, blood and urine compositions with conventional methods such as enzyme-linked immunosorbent assay and radioimmunoassay, kidney histology, and renal expressions of various genes were analyzed. In vitro studies were also performed to support in vivo findings. Results: Klotho protein supplementation decreased albuminuria (−43%), systolic blood pressure (−16%), fibroblast growth factor (FGF) 23 (−51%) and serum phosphate levels (−19%), renal angiotensin II concentration (−43%), fibrosis index (−70%), renal expressions of collagen I (−55%), and transforming growth factor β (−59%) (p &lt; 0.05 for all). Klotho supplementation enhanced fractional excretion of phosphate (+45%), glomerular filtration rate (+76%), renal expressions of klotho (+148%), superoxide dismutase (+124%), and bone morphogenetic protein (BMP) 7 (+174%) (p &lt; 0.05 for all). Conclusion: Our data indicated that klotho protein supplementation inactivated renal renin-angiotensin system, reducing blood pressure and albuminuria in remnant kidney. Furthermore, exogenous klotho protein supplementation elevated endogenous klotho expression to increase phosphate excretion with resultant reductions in FGF23 and serum phosphate. Finally, klotho supplementation reversed renal dysfunction and fibrosis in association with improved BMP7 in remnant kidney.</description><identifier>ISSN: 1420-4096</identifier><identifier>EISSN: 1423-0143</identifier><identifier>DOI: 10.1159/000530469</identifier><identifier>PMID: 37019097</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Angiotensin ; Angiotensin II ; Animals ; Antibiotics ; Apoptosis ; Blood pressure ; Bone morphogenetic proteins ; Collagen (type I) ; Enzyme-linked immunosorbent assay ; Enzymes ; Excretion ; Fibroblast growth factor 23 ; Fibroblasts ; Fibrosis ; Glomerular filtration rate ; Growth factors ; Histology ; Impact damage ; In vivo methods and tests ; Insulin-like growth factors ; Kidney diseases ; Kidneys ; Klotho protein ; Nephrectomy ; Proteins ; Radioimmunoassay ; Renal function ; Renin ; Research Article ; Superoxide dismutase ; Supplements ; Transforming growth factor-b ; Urine ; Veins &amp; arteries</subject><ispartof>Kidney &amp; blood pressure research, 2023-01, Vol.48 (1), p.326-337</ispartof><rights>2023 The Author(s). Published by S. Karger AG, Basel</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel.</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-47e797d0c369c8c15ae03a9fb367ada8a0cf2125266721c220e7f71960463b3b3</citedby><cites>FETCH-LOGICAL-c529t-47e797d0c369c8c15ae03a9fb367ada8a0cf2125266721c220e7f71960463b3b3</cites><orcidid>0000-0002-3383-1340 ; 0000-0001-5971-820X ; 0000-0002-1613-1887</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,2102,27635,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37019097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takenaka, Tsuneo</creatorcontrib><creatorcontrib>Hasan, Arif</creatorcontrib><creatorcontrib>Marumo, Takeshi</creatorcontrib><creatorcontrib>Inoue, Tsutomu</creatorcontrib><creatorcontrib>Miyazaki, Takashi</creatorcontrib><creatorcontrib>Suzuki, Hiromichi</creatorcontrib><creatorcontrib>Kurosaki, Yoshifumi</creatorcontrib><creatorcontrib>Ishii, Naohito</creatorcontrib><creatorcontrib>Nishiyama, Akira</creatorcontrib><creatorcontrib>Hayashi, Matsuhiko</creatorcontrib><title>Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney</title><title>Kidney &amp; blood pressure research</title><addtitle>Kidney Blood Press Res</addtitle><description>Abstract Introduction: While recent investigations show that klotho exerts renoprotective actions, it has not been fully addressed whether klotho protein supplementation reverses renal damage. Methods: The impacts of subcutaneous klotho supplementation on rats with subtotal nephrectomy were examined. Animals were divided into 3 groups: group 1 (short remnant [SR]): remnant kidney for 4 weeks, group 2 (long remnant [LR]): remnant kidney for 12 weeks, and group 3 (klotho supplementation [KL]): klotho protein (20 μg/kg/day) supplementation on the remnant kidney. Blood pressure, blood and urine compositions with conventional methods such as enzyme-linked immunosorbent assay and radioimmunoassay, kidney histology, and renal expressions of various genes were analyzed. In vitro studies were also performed to support in vivo findings. Results: Klotho protein supplementation decreased albuminuria (−43%), systolic blood pressure (−16%), fibroblast growth factor (FGF) 23 (−51%) and serum phosphate levels (−19%), renal angiotensin II concentration (−43%), fibrosis index (−70%), renal expressions of collagen I (−55%), and transforming growth factor β (−59%) (p &lt; 0.05 for all). Klotho supplementation enhanced fractional excretion of phosphate (+45%), glomerular filtration rate (+76%), renal expressions of klotho (+148%), superoxide dismutase (+124%), and bone morphogenetic protein (BMP) 7 (+174%) (p &lt; 0.05 for all). Conclusion: Our data indicated that klotho protein supplementation inactivated renal renin-angiotensin system, reducing blood pressure and albuminuria in remnant kidney. Furthermore, exogenous klotho protein supplementation elevated endogenous klotho expression to increase phosphate excretion with resultant reductions in FGF23 and serum phosphate. Finally, klotho supplementation reversed renal dysfunction and fibrosis in association with improved BMP7 in remnant kidney.</description><subject>Angiotensin</subject><subject>Angiotensin II</subject><subject>Animals</subject><subject>Antibiotics</subject><subject>Apoptosis</subject><subject>Blood pressure</subject><subject>Bone morphogenetic proteins</subject><subject>Collagen (type I)</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>Excretion</subject><subject>Fibroblast growth factor 23</subject><subject>Fibroblasts</subject><subject>Fibrosis</subject><subject>Glomerular filtration rate</subject><subject>Growth factors</subject><subject>Histology</subject><subject>Impact damage</subject><subject>In vivo methods and tests</subject><subject>Insulin-like growth factors</subject><subject>Kidney diseases</subject><subject>Kidneys</subject><subject>Klotho protein</subject><subject>Nephrectomy</subject><subject>Proteins</subject><subject>Radioimmunoassay</subject><subject>Renal function</subject><subject>Renin</subject><subject>Research Article</subject><subject>Superoxide dismutase</subject><subject>Supplements</subject><subject>Transforming growth factor-b</subject><subject>Urine</subject><subject>Veins &amp; arteries</subject><issn>1420-4096</issn><issn>1423-0143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DOA</sourceid><recordid>eNptkc-L1TAQx4so7rp68C5S8KKH6iRpk-a4rq4-3oKw6lFCmk7XPNukJqnw_nvzfvgEkRwyzHzy_U5miuIpgdeENPINADQMai7vFeekpqwCUrP7-xiqGiQ_Kx7FuNlhAPRhccYEEAlSnBff1qNP3335eZnnESd0SSfrXXmLvzBEjDlweizfbeOwOLMvadeXK5dyOdlkc_HadsFHG0u7ezc57VK5tr3D7ePiwaDHiE-O90Xx9fr9l6uP1c2nD6ury5vKNFSmqhYopOjBMC5Na0ijEZiWQ8e40L1uNZiBEtpQzgUlhlJAMQgief4z6_K5KFYH3d7rjZqDnXTYKq-t2id8uFM6JGtGVF0nZN31LVDkteBSQt90WlMEnb0JZq2XB605-J8LxqQmGw2Oo3bol6hobpXUvKVtRl_8g278EvK8MiWBC85Y22Tq1YEyeUox4HBqkIDa7U-d9pfZ50fFpZuwP5F_FvbX8ocOdxhOwPrt7UFCzf2QqWf_pY4uvwFLNKjD</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Takenaka, Tsuneo</creator><creator>Hasan, Arif</creator><creator>Marumo, Takeshi</creator><creator>Inoue, Tsutomu</creator><creator>Miyazaki, Takashi</creator><creator>Suzuki, Hiromichi</creator><creator>Kurosaki, Yoshifumi</creator><creator>Ishii, Naohito</creator><creator>Nishiyama, Akira</creator><creator>Hayashi, Matsuhiko</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3383-1340</orcidid><orcidid>https://orcid.org/0000-0001-5971-820X</orcidid><orcidid>https://orcid.org/0000-0002-1613-1887</orcidid></search><sort><creationdate>20230101</creationdate><title>Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney</title><author>Takenaka, Tsuneo ; Hasan, Arif ; Marumo, Takeshi ; Inoue, Tsutomu ; Miyazaki, Takashi ; Suzuki, Hiromichi ; Kurosaki, Yoshifumi ; Ishii, Naohito ; Nishiyama, Akira ; Hayashi, Matsuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-47e797d0c369c8c15ae03a9fb367ada8a0cf2125266721c220e7f71960463b3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Angiotensin</topic><topic>Angiotensin II</topic><topic>Animals</topic><topic>Antibiotics</topic><topic>Apoptosis</topic><topic>Blood pressure</topic><topic>Bone morphogenetic proteins</topic><topic>Collagen (type I)</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>Excretion</topic><topic>Fibroblast growth factor 23</topic><topic>Fibroblasts</topic><topic>Fibrosis</topic><topic>Glomerular filtration rate</topic><topic>Growth factors</topic><topic>Histology</topic><topic>Impact damage</topic><topic>In vivo methods and tests</topic><topic>Insulin-like growth factors</topic><topic>Kidney diseases</topic><topic>Kidneys</topic><topic>Klotho protein</topic><topic>Nephrectomy</topic><topic>Proteins</topic><topic>Radioimmunoassay</topic><topic>Renal function</topic><topic>Renin</topic><topic>Research Article</topic><topic>Superoxide dismutase</topic><topic>Supplements</topic><topic>Transforming growth factor-b</topic><topic>Urine</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takenaka, Tsuneo</creatorcontrib><creatorcontrib>Hasan, Arif</creatorcontrib><creatorcontrib>Marumo, Takeshi</creatorcontrib><creatorcontrib>Inoue, Tsutomu</creatorcontrib><creatorcontrib>Miyazaki, Takashi</creatorcontrib><creatorcontrib>Suzuki, Hiromichi</creatorcontrib><creatorcontrib>Kurosaki, Yoshifumi</creatorcontrib><creatorcontrib>Ishii, Naohito</creatorcontrib><creatorcontrib>Nishiyama, Akira</creatorcontrib><creatorcontrib>Hayashi, Matsuhiko</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Kidney &amp; blood pressure research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takenaka, Tsuneo</au><au>Hasan, Arif</au><au>Marumo, Takeshi</au><au>Inoue, Tsutomu</au><au>Miyazaki, Takashi</au><au>Suzuki, Hiromichi</au><au>Kurosaki, Yoshifumi</au><au>Ishii, Naohito</au><au>Nishiyama, Akira</au><au>Hayashi, Matsuhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney</atitle><jtitle>Kidney &amp; blood pressure research</jtitle><addtitle>Kidney Blood Press Res</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>48</volume><issue>1</issue><spage>326</spage><epage>337</epage><pages>326-337</pages><issn>1420-4096</issn><eissn>1423-0143</eissn><abstract>Abstract Introduction: While recent investigations show that klotho exerts renoprotective actions, it has not been fully addressed whether klotho protein supplementation reverses renal damage. Methods: The impacts of subcutaneous klotho supplementation on rats with subtotal nephrectomy were examined. Animals were divided into 3 groups: group 1 (short remnant [SR]): remnant kidney for 4 weeks, group 2 (long remnant [LR]): remnant kidney for 12 weeks, and group 3 (klotho supplementation [KL]): klotho protein (20 μg/kg/day) supplementation on the remnant kidney. Blood pressure, blood and urine compositions with conventional methods such as enzyme-linked immunosorbent assay and radioimmunoassay, kidney histology, and renal expressions of various genes were analyzed. In vitro studies were also performed to support in vivo findings. Results: Klotho protein supplementation decreased albuminuria (−43%), systolic blood pressure (−16%), fibroblast growth factor (FGF) 23 (−51%) and serum phosphate levels (−19%), renal angiotensin II concentration (−43%), fibrosis index (−70%), renal expressions of collagen I (−55%), and transforming growth factor β (−59%) (p &lt; 0.05 for all). Klotho supplementation enhanced fractional excretion of phosphate (+45%), glomerular filtration rate (+76%), renal expressions of klotho (+148%), superoxide dismutase (+124%), and bone morphogenetic protein (BMP) 7 (+174%) (p &lt; 0.05 for all). Conclusion: Our data indicated that klotho protein supplementation inactivated renal renin-angiotensin system, reducing blood pressure and albuminuria in remnant kidney. Furthermore, exogenous klotho protein supplementation elevated endogenous klotho expression to increase phosphate excretion with resultant reductions in FGF23 and serum phosphate. Finally, klotho supplementation reversed renal dysfunction and fibrosis in association with improved BMP7 in remnant kidney.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>37019097</pmid><doi>10.1159/000530469</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-3383-1340</orcidid><orcidid>https://orcid.org/0000-0001-5971-820X</orcidid><orcidid>https://orcid.org/0000-0002-1613-1887</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-4096
ispartof Kidney & blood pressure research, 2023-01, Vol.48 (1), p.326-337
issn 1420-4096
1423-0143
language eng
recordid cdi_proquest_journals_2906763385
source DOAJ Directory of Open Access Journals; Karger Open Access; EZB-FREE-00999 freely available EZB journals
subjects Angiotensin
Angiotensin II
Animals
Antibiotics
Apoptosis
Blood pressure
Bone morphogenetic proteins
Collagen (type I)
Enzyme-linked immunosorbent assay
Enzymes
Excretion
Fibroblast growth factor 23
Fibroblasts
Fibrosis
Glomerular filtration rate
Growth factors
Histology
Impact damage
In vivo methods and tests
Insulin-like growth factors
Kidney diseases
Kidneys
Klotho protein
Nephrectomy
Proteins
Radioimmunoassay
Renal function
Renin
Research Article
Superoxide dismutase
Supplements
Transforming growth factor-b
Urine
Veins & arteries
title Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A21%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Klotho%20Supplementation%20Reverses%20Renal%20Dysfunction%20and%20Interstitial%20Fibrosis%20in%20Remnant%20Kidney&rft.jtitle=Kidney%20&%20blood%20pressure%20research&rft.au=Takenaka,%20Tsuneo&rft.date=2023-01-01&rft.volume=48&rft.issue=1&rft.spage=326&rft.epage=337&rft.pages=326-337&rft.issn=1420-4096&rft.eissn=1423-0143&rft_id=info:doi/10.1159/000530469&rft_dat=%3Cproquest_doaj_%3E2797146828%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2906763385&rft_id=info:pmid/37019097&rft_doaj_id=oai_doaj_org_article_bb794bd802e6476990d5baa2e0a9c81e&rfr_iscdi=true